A Falmouth teen, Jayden Wilsey, is the first to receive gene therapy to treat sickle cell at Boston Children's Hospital.

New gene therapy improves the life of 18-year-old with Sickle Cell Disease which affects 5,000 New Jersey residents living ...

The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at MUSC have joined forces to create and test an ...

Beam Therapeutics (NASDAQ:BEAM) gains FDA orphan drug status for BEAM-101 to treat sickle cell disease. Read more here.

Sickle Cell Disease is a chronic, inherited blood disorder that affects millions of people worldwide. It is best known for causing anaemia, pain episodes, and organ complications, but a lesser ...

MOST COMMON GENETIC BLOOD DISORDER IN THE U.S. SO TODAY, WE REALLY WANTED TO FOCUS ON SOMETHING THAT AFFECTS THE BLACK COMMUNITY AND STUDENTS. SO SICKLE CELL WAS SOMETHING THAT IS IMPORTANT TO US.

To boost awareness and early intervention, the Ministry of Health Family Welfare urges citizens to recognise the warning ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

HILLSBOROUGH COUNTY, Fla. — There is an incredible story of love and sacrifice out of Plant City that helped to heal a little girl from sickle cell disease. Aliyah Reid spent the first five ...

The center supports individuals living with thalassemia and sickle cell disease by delivering a holistic, patient-centric, and evidence-based model of care ABU DHABI: Under the patronage and in the ...

May 14, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines ... trial of BEAM-101 in sickle cell disease (SCD) at the ...

A 30-year-old mother is demanding change through a petition after suffering with one of the most common genetic disorders all her life. Portia Wharton has lived with Sickle Cell Disease for the ...